2.4. Expression of PSMD2, PSMD6, PSMD7, and PSMD9 Are Elevated in AML Patients with Mutated versus Wild-Type FLT3, Which Correlated with Worse Outcomes. Here, PSMD9 is linked to acute myeloid leukemia.